Form D · Pharmaceuticals
USWM Enterprises, LLC
Louisville, KY · CIK 0001737326
Offering snapshot reported Apr 13, 2018 · SEC filing
- Reported sold
- $12.2M Offering amount: $30M
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $99K Reported outside-investor minimum
- First sale
- Jun 5, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 13, 2018 | Initial | $12,163,470 | No comparison | 30 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-310076
Source: Form D, filed Apr 13, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James T. Crain, Iii | Director |
| George A. Digenis | Director, Executive |
| P Breckinridge Jones | Director, Executive |
| Henry Van Den Berg | Executive |
| H. Lee Warren, Jr. | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4441 Springdale Road
Louisville, KY, 40241
Louisville, KY, 40241